INGLIS TIFFANY EUL DAVIS (Chief Medical Officer) received a stock award from SERA PROGNOSTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/13/2026ACC: 0001193125-26-106590
Officer· Chief Medical Officer
Since Mar 2026
+44.47K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
44.47K acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+17.44K
Price / share
—
Trade value
—
% of position
23.2%
3/12/2026
75K→92.44K
Total
Net shares
+17.44K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 3/12/2026 | A · Award | +17.44K | — | — | 23.2% | 75K | 92.44K |
| Total | +17.44K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Class A Common Stock
27.03K shares
Shares
+27.03K
Strike price
1.99
Held after
27.03K
Exercisable
—
3/12/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Class A Common Stock27.03K shares | 3/12/2026 | A · Award | +27.03K | 1.99 | — | 27.03K |